Biology of neoplasia
Tolerance and Cancer: Mechanisms of Tumor Evasion and Strategies for Breaking Tolerance
Breast Cancer
Hormone Replacement Therapy and Life Expectancy After Prophylactic Oophorectomy in Women With BRCA1/2 Mutations: A Decision Analysis
Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group
Safety of Treatment of Metastatic Breast Cancer With Trastuzumab Beyond Disease Progression
Docetaxel Combined With Trastuzumab Is an Active Regimen in HER-2 3+ Overexpressing and Fluorescent In Situ Hybridization–Positive Metastatic Breast Cancer: A Multi-Institutional Phase II Trial
Diagnosis in oncology
Unusual Sites of Metastatic Involvement: CASE 1. Right Ventricular Outflow Obstruction Caused by Metastatic Hepatocellular Carcinoma
Unusual Sites of Metastatic Involvement: CASE 2. Intracardiac Metastasis From a Merkel Cell Carcinoma
Unusual Sites of Metastatic Involvement: CASE 3. Grey-Turner's Sign As the First Indication of a Ruptured Hepatocellular Carcinoma
Editorial
p53 and RB: Simple Interesting Correlates or Tumor Markers of Critical Predictive Nature?
Prophylactic Oophorectomy and Hormone Replacement Therapy: Protection at What Price?
Prophylactic Mastectomy for BRCA1/2 Carriers: Progress and More Questions
Genitourinary Cancer
Combined Effects of p53, p21, and pRb Expression in the Progression of Bladder Transitional Cell Carcinoma
p53, p21, pRB, and p16 Expression Predict Clinical Outcome in Cystectomy With Bladder Cancer
Antiandrogen Withdrawal Alone or in Combination With Ketoconazole in Androgen-Independent Prostate Cancer Patients: A Phase III Trial (CALGB 9583)
18fluoro-deoxy-D-glucose Positron Emission Tomography Is a Reliable Predictor for Viable Tumor in Postchemotherapy Seminoma: An Update of the Prospective Multicentric SEMPET Trial
Gynecologic Cancer
Mucinous Epithelial Ovarian Cancer: A Separate Entity Requiring Specific Treatment
Hematologic Malignancies
Mitoxantrone, Etoposide, and Cytarabine With or Without Valspodar in Patients With Relapsed or Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome: A Phase III Trial (E2995)
Repetitive Cycles of High-Dose Cytarabine Benefit Patients With Acute Myeloid Leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): Results from CALGB 8462
Rapid Mobilization of CD34+ Cells Following Administration of the CXCR4 Antagonist AMD3100 to Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma
Lung cancer
Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non–Small-Cell Lung Cancer
Phase I Study of G3139, a bcl-2 Antisense Oligonucleotide, Combined With Carboplatin and Etoposide in Patients With Small-Cell Lung Cancer
Melanoma
Fotemustine Compared With Dacarbazine in Patients With Disseminated Malignant Melanoma: A Phase III Study
Pediatric Oncology
Clinical, Histopathologic, and Molecular Markers of Prognosis: Toward a New Disease Risk Stratification System for Medulloblastoma
Combining Gene Expression Profiles and Clinical Parameters for Risk Stratification in Medulloblastomas
Psychological Outcomes in Long-Term Survivors of Childhood Brain Cancer: A Report From the Childhood Cancer Survivor Study
Review Articles
Evaluation of Diagnostic Assessment Units in Oncology: A Systematic Review
